Keros Therapeutics
KROS
KROS
83 hedge funds and large institutions have $887M invested in Keros Therapeutics in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
8.01% less ownership
Funds ownership: 79.39% → 71.38% (-8%)
21% less capital invested
Capital invested by funds: $1.13B → $887M (-$242M)
Holders
83
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$20.5M | |
| 2 | +$18.3M | |
| 3 | +$17.4M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$9.69M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$6.73M |
Top Sellers
| 1 | -$132M | |
| 2 | -$31.7M | |
| 3 | -$18.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.7M |
| 5 |
Goldman Sachs
New York
|
-$7.24M |